BackgroundCheck.run
Search For

Kevin K Pang, 6242 Mohawk Rd, Canton, MA 02021

Kevin Pang Phones & Addresses

42 Mohawk Rd, Canton, MA 02021    781-5620170   

53 Hill Rd, Belmont, MA 02478    617-4899642   

Berkeley, CA   

Arlington, MA   

Allston, MA   

42 Mohawk Rd, Canton, MA 02021    781-7274481   

Work

Position: Professional/Technical

Mentions for Kevin K Pang

Career records & work history

License Records

Kevin Shing Pang Liou

Licenses:
License #: E078955 - Active
Category: Emergency medical services
Issued Date: Jan 25, 2011
Expiration Date: Mar 31, 2018
Type: Oakland City FD

Kevin Pang resumes & CV records

Resumes

Kevin Pang Photo 36

Kevin Pang Ab Comp Pang

Kevin Pang Photo 37

Algorithmic Trader

Location:
Chicago, Illinois
Industry:
Financial Services
Kevin Pang Photo 38

Kevin Pang

Location:
Greater Boston Area
Industry:
Information Technology and Services

Publications & IP owners

Us Patents

Progenitor Cells And Methods And Uses Related Thereto

US Patent:
6610535, Aug 26, 2003
Filed:
Nov 28, 2000
Appl. No.:
09/724632
Inventors:
Kuanghui Lu - Brookline MA
Kevin Pang - Canton MA
Lee Rubin - Wellesley MA
Assignee:
ES Cell International Pte Ltd.
International Classification:
C12N 500
US Classification:
435325, 435363, 435366, 4353722, 435375, 435377, 435384, 435387, 435391, 435392
Abstract:
The present invention relates to a substantially pure population of viable pancreatic progenitor cells, and methods for isolating such cells. The present invention further concerns certain therapeutic uses for such progenitor cells, and their progeny.

Progenitor Cells, Methods And Uses Related Thereto

US Patent:
6946293, Sep 20, 2005
Filed:
Aug 9, 2000
Appl. No.:
09/635370
Inventors:
Kuanghui Lu - Brookline MA, US
Kevin Pang - Belmont MA, US
Lee Rubin - Wellesley MA, US
International Classification:
C12N005/06
US Classification:
435378, 435325, 435379, 435381, 435383, 435384, 435385
Abstract:
The present invention relates to a substantially pure population of viable pancreatic progenitor cells, and methods for isolating such cells. The present invention further concerns certain therapeutic uses for such progenitor cells, and their progeny.

Method Of Treating Dopaminergic And Gaba-Nergic Disorders

US Patent:
7138492, Nov 21, 2006
Filed:
Dec 1, 1999
Appl. No.:
09/451939
Inventors:
Ningning Miao - Palo Alto CA, US
Monica Wang - Marblehead MA, US
Nagesh K. Mahanthappa - Cambridge MA, US
Ping Jin - Boston MA, US
Kevin Pang - Belmont MA, US
Assignee:
Curis, Inc. - Cambridge MA
International Classification:
C07H 12/04
C12N 15/63
C12N 15/12
C12N 1/15
US Classification:
530350, 435 691, 4352523, 435325, 436501, 530300, 53038822, 514 2
Abstract:
It is shown here that hedgehog proteins possess novel activities beyond phenotype specification. Using cultures derived from the embryonic day 14. 5 (E14. 5) rat ventral mesencephalon, we show that hedgehog is also trophic for dopaminergic neurons. Interestingly, hedgehog not only promotes dopaminergic neuron survival, but also promotes the survival of midbrain GABA-immunoreactive (GABA-ir) neurons.

Vertebrate Embryonic Patterning-Inducing Proteins, Compositions And Uses Related Therto

US Patent:
7144997, Dec 5, 2006
Filed:
Jul 24, 1997
Appl. No.:
08/900220
Inventors:
Ningning Miao - Cambridge MA, US
Monica Wang - Marblehead MA, US
Nagesh K. Mahanthappa - Cambridge MA, US
Kevin Pang - Belmont MA, US
Assignee:
Curis, Inc. - Cambridge MA
International Classification:
C07H 12/04
C12N 15/63
C12N 15/12
C12N 1/15
US Classification:
536 2351, 435 691, 435 693, 4352523, 435325, 436501, 530300, 530350, 514 2
Abstract:
It is shown here that hedgehog proteins possess novel activities beyond phenotype specification. Using cultures derived from the embryonic day 14. 5 (E14. 5) rat ventral mesencephalon, we show that hedgehog is also trophic for dopaminergic neurons. Interestingly, hedgehog not only promotes dopaminergic neuron survival, but also promotes the survival of midbrain GABA-immunoreactive (GABA-ir) neurons.

Methods And Reagents For Treating Glucose Metabolic Disorders

US Patent:
7396809, Jul 8, 2008
Filed:
Feb 10, 2000
Appl. No.:
09/499526
Inventors:
Kuanghui Lu - Brookline MA, US
Kevin Pang - Belmont MA, US
Assignee:
Curis, Inc. - Cambridge MA
International Classification:
C12N 5/06
A61K 38/22
C07K 14/575
US Classification:
514 2, 514 12, 530399, 435366, 435375
Abstract:
The invention relates to methods for potentiating, enhancing or restoring glucose responsivity in pancreatic islets or cells. The methods can be used as therapies for diseases caused by, or coincident with, aberrant glucose metabolism, such as Type II Diabetes Mellitus.

Methods And Reagents For Treating Glucose Metabolic Disorders

US Patent:
7745216, Jun 29, 2010
Filed:
May 27, 2004
Appl. No.:
10/855676
Inventors:
Kevin Pang - Belmont MA, US
Kuanghui Lu - Brookline MA, US
Assignee:
Curis, Inc. - Cambridge MA
International Classification:
C12N 5/071
A61K 38/00
A61K 38/18
A61K 38/22
US Classification:
435366, 435375, 530307, 530324
Abstract:
The invention relates to methods for potentiating, enhancing or restoring glucose responsivity in pancreatic islets or cells. The methods can be used as therapies for diseases caused by, or coincident with, aberrant glucose metabolism, such as Type II Diabetes Mellitus.

Methods And Reagents For Treating Glucose Metabolic Disorders

US Patent:
7807641, Oct 5, 2010
Filed:
Feb 6, 2007
Appl. No.:
11/702776
Inventors:
Kevin Pang - Belmont MA, US
Kuanghui Lu - Brookline MA, US
Assignee:
Curis, Inc. - Cambridge MA
International Classification:
A61K 38/22
C07K 14/575
US Classification:
514 12, 530324
Abstract:
The invention relates to methods for potentiating, enhancing or restoring glucose responsivity in pancreatic islets or cells. The methods can be used as therapies for diseases caused by, or coincident with, aberrant glucose metabolism, such as Type II Diabetes Mellitus.

Bile Duct Progenitor Cells And Methods Of Use

US Patent:
2002001, Jan 31, 2002
Filed:
Dec 19, 1997
Appl. No.:
08/994539
Inventors:
KEVIN PANG - BELMONT MA, US
MONICA HOMA - MARBLEHEAD MA, US
International Classification:
A61K048/00
C12N005/06
US Classification:
424/093100, 435/325000, 435/001100
Abstract:
The present invention relates to a substantially pure population of viable bile duct progenitor cells, and methods for isolating such cells. The present invention further concerns certain therapeutic uses for such progenitor cells, and their progeny.

Amazon

Kevin Pang Photo 43

Printers Row Journal, March 25, 2012

Author:
Kevin Pang, Mark Caro, Julia Keller, Elizabeth Taylor
Binding:
Kindle Edition
Pages:
99
Printers Row is the Chicago Tribune's weekly journal of books and literature. This week: Kevin Pang interviews Sarah Vowell; Christopher Borrelli and Mark Caro debate the casting in "The Hunger Games"; Chris Jones interviews Rachel Dratch; fiction from Joe Meno; best sellers, book reviews and more.
Kevin Pang Photo 44

New Measles Virus Genotype Associated With Outbreak, China.(Research): An Article From: Emerging Infectious Diseases

Author:
Yan Zhang, Zhengrong Ding, Huiling Wang, Liqun Li, Yankun Pang, Kevin E. Brown, Songtao Xu, Zhen Zhu, Paul A. Rota, David Featherstone, Wenbo Xu
Publisher:
U.S. National Center for Infectious Diseases
Binding:
Digital
Pages:
11
This digital document is an article from Emerging Infectious Diseases, published by U.S. National Center for Infectious Diseases on June 1, 2010. The length of the article is 3269 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is a...
Kevin Pang Photo 45

Skull Base Osteomyelitis Originating In The Middle Ear Or Mastoid: A Review Of 3 Cases.(Original Article): An Article From: Ear, Nose And Throat Journal

Author:
Aaron Pang, Kevin Chong
Publisher:
Vendome Group LLC
Binding:
Digital
Pages:
7
This digital document is an article from Ear, Nose and Throat Journal, published by Vendome Group LLC on March 1, 2011. The length of the article is 2034 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after...

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.